title: Stimulation of phagocytosis and phagosome-lysosome (P-L) fusion of human polymorphonuclear leukocytes by sulfatide (galactosylceramide-3-sulfate).
abstract: Recently, extensive attention has been paid to the physiological function of glycosphingolipids (GSLs) of mammalian cell membranes. Among a variety of GSLs, sulfatide (galactosylceramide-3-sulfate) has been proposed to be a specific receptor or binding molecule to microorganisms. However, no report has appeared on the direct stimulation by sulfatide for cellular function differentiation in phagocytic cells. We found that sulfatide showed a marked stimulation for phagocytic processes of human peripheral polymorphonuclear leukocytes (PMN) using heat-killed cells of Staphylococcus aureus coated with isolated lipid. Among mammalian acidic GSLs, sulfatide showed the highest stimulative activity for adhesion, phagocytosis and phagosome-lysosome (P-L) fusion by PMN. On the other hand, neutral GSLs did not stimulate essentially. Relative phagocytic rate of sulfatide-coated staphylococci was six times higher than that of the non-coated control and P-L fusion rate was ten times at maximum, respectively. Although the promotion mechanism of sulfatide for such phagocytosis or P-L fusion is not clear, it was strongly suggested that the existence of negative charges on carbohydrate moiety may be essential for the induction of differentiation of phagocytic cell function via signal transduction systems.
authors.affiliation: Department of Bacteriology, Osaka City University Medical School, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Yamaguchi
authors.forename: Y
authors.initials: Y
authors.lastname: Miyazaki
authors.forename: S
authors.initials: S
authors.lastname: Oka
authors.forename: I
authors.initials: I
authors.lastname: Yano
mesh_terms: D002459:Cell Fusion / Q000187:drug effects; D002554:Cerebrosides / Q000494:pharmacology*; D005699:Galactosylceramides / Q000494:pharmacology*; D006801:Humans; D008247:Lysosomes / Q000187:drug effects*; D009504:Neutrophils / Q000166:cytology / Q000187:drug effects*; D010587:Phagocytosis / Q000187:drug effects*; D010588:Phagosomes / Q000187:drug effects*; D013211:Staphylococcus aureus / Q000378:metabolism; D013433:Sulfoglycosphingolipids / Q000494:pharmacology*; D013481:Superoxides / Q000097:blood
chemical_list: D002554:Cerebrosides; D005699:Galactosylceramides; D013433:Sulfoglycosphingolipids; C083015:cerebroside sulfate; D013481:Superoxides